Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.2 Unpaid Sources
1.5.3 Primary
Chapter 2 Executive Summary
2.1 Imaging agents industry 3600 synopsis, 2017 - 2030
2.2 Business trends
2.2.1 Product type trends
2.2.2 Application trends
2.2.3 Modality trends
2.2.4 End-use trends
2.2.5 Regional trends
Chapter 3 Imaging Agents Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 – 2030 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rapidly growing cancer and CVD population across the globe
3.3.1.2 Surging innovation in imaging procedures and agents
3.3.1.3 Rising demand for image-guided procedures
3.3.1.4 Increasing healthcare expenditure
3.3.2 Restraints
3.3.2.1 High costs of imaging agents and procedures
3.3.2.2 Side effects associated with the imaging agents and diagnostic imaging procedures
3.4 Growth potential analysis
3.4.1 By product type
3.4.2 By application
3.4.3 By modality
3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Competitive landscape, 2021
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Imaging Agents Market, By Product Type
4.1 Key segment trends
4.2 Iodinated contrast media
4.2.1 Market size, by region, 2017-2030 (USD Million)
4.3 Gadolinium-based contrast media
4.3.1 Market size, by region, 2017-2030 (USD Million)
4.4 Microbubble contrast media
4.4.1 Market size, by region, 2017-2030 (USD Million)
4.5 Barium-based contrast media
4.5.1 Market size, by region, 2017-2030 (USD Million)
Chapter 5 Imaging Agents Market, By Application
5.1 Key segment trends
5.2 Oncology
5.2.1 Market size, by region, 2017-2030 (USD Million)
5.3 Cardiology
5.3.1 Market size, by region, 2017-2030 (USD Million)
5.4 Gastrointestinal
5.4.1 Market size, by region, 2017-2030 (USD Million)
5.5 Neurology
5.5.1 Market size, by region, 2017-2030 (USD Million)
5.6 Others
5.6.1 Market size, by region, 2017-2030 (USD Million)
Chapter 6 Imaging Agents Market, By Modality
6.1 Key segment trends
6.2 X-Ray
6.2.1 Market size, by region, 2017-2030 (USD Million)
6.3 Computed Tomography (CT)
6.3.1 Market size, by region, 2017-2030 (USD Million)
6.4 Magnetic Resonance Imaging (MRI)
6.4.1 Market size, by region, 2017-2030 (USD Million)
6.5 Ultrasound
6.5.1 Market size, by region, 2017-2030 (USD Million)
6.6 Others
6.6.1 Market size, by region, 2017-2030 (USD Million)
Chapter 7 Imaging Agents Market, By End-use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market size, by region, 2017-2030 (USD Million)
7.3 Ambulatory surgical centers
7.3.1 Market size, by region, 2017-2030 (USD Million)
7.4 Diagnostic & imaging centers
7.4.1 Market size, by region, 2017-2030 (USD Million)
7.5 Others
7.5.1 Market size, by region, 2017-2030 (USD Million)
Chapter 8 Imaging Agents Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2017-2030 (USD Million)
8.2.2 Market size, by product type, 2017-2030 (USD Million)
8.2.3 Market size, by application, 2017-2030 (USD Million)
8.2.4 Market size, by modality, 2017-2030 (USD Million)
8.2.5 Market size, by end-use, 2017-2030 (USD Million)
8.2.6 U.S.
8.2.6.1 Market size, by product type, 2017-2030 (USD Million)
8.2.6.2 Market size, by application, 2017-2030 (USD Million)
8.2.6.3 Market size, by modality, 2017-2030 (USD Million)
8.2.6.4 Market size, by end-use, 2017-2030 (USD Million)
8.2.7 Canada
8.2.7.1 Market size, by product type, 2017-2030 (USD Million)
8.2.7.2 Market size, by application, 2017-2030 (USD Million)
8.2.7.3 Market size, by modality, 2017-2030 (USD Million)
8.2.7.4 Market size, by end-use, 2017-2030 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2017-2030 (USD Million)
8.3.2 Market size, by product type, 2017-2030 (USD Million)
8.3.3 Market size, by application, 2017-2030 (USD Million)
8.3.4 Market size, by modality, 2017-2030 (USD Million)
8.3.5 Market size, by end-use, 2017-2030 (USD Million)
8.3.6 Germany
8.3.6.1 Market size, by product type, 2017-2030 (USD Million)
8.3.6.2 Market size, by application, 2017-2030 (USD Million)
8.3.6.3 Market size, by modality, 2017-2030 (USD Million)
8.3.6.4 Market size, by end-use, 2017-2030 (USD Million)
8.3.7 France
8.3.7.1 Market size, by product type, 2017-2030 (USD Million)
8.3.7.2 Market size, by application, 2017-2030 (USD Million)
8.3.7.3 Market size, by modality, 2017-2030 (USD Million)
8.3.7.4 Market size, by end-use, 2017-2030 (USD Million)
8.3.8 UK
8.3.8.1 Market size, by product type, 2017-2030 (USD Million)
8.3.8.2 Market size, by application, 2017-2030 (USD Million)
8.3.8.3 Market size, by modality, 2017-2030 (USD Million)
8.3.8.4 Market size, by end-use, 2017-2030 (USD Million)
8.3.9 Italy
8.3.9.1 Market size, by product type, 2017-2030 (USD Million)
8.3.9.2 Market size, by application, 2017-2030 (USD Million)
8.3.9.3 Market size, by modality, 2017-2030 (USD Million)
8.3.9.4 Market size, by end-use, 2017-2030 (USD Million)
8.3.10 Spain
8.3.10.1 Market size, by product type, 2017-2030 (USD Million)
8.3.10.2 Market size, by application, 2017-2030 (USD Million)
8.3.10.3 Market size, by modality, 2017-2030 (USD Million)
8.3.10.4 Market size, by end-use, 2017-2030 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2017-2030 (USD Million)
8.4.2 Market size, by product type, 2017-2030 (USD Million)
8.4.3 Market size, by application, 2017-2030 (USD Million)
8.4.4 Market size, by modality, 2017-2030 (USD Million)
8.4.5 Market size, by end-use, 2017-2030 (USD Million)
8.4.6 China
8.4.6.1 Market size, by product type, 2017-2030 (USD Million)
8.4.6.2 Market size, by application, 2017-2030 (USD Million)
8.4.6.3 Market size, by modality, 2017-2030 (USD Million)
8.4.6.4 Market size, by end-use, 2017-2030 (USD Million)
8.4.7 Japan
8.4.7.1 Market size, by product type, 2017-2030 (USD Million)
8.4.7.2 Market size, by application, 2017-2030 (USD Million)
8.4.7.3 Market size, by modality, 2017-2030 (USD Million)
8.4.7.4 Market size, by end-use, 2017-2030 (USD Million)
8.4.8 India
8.4.8.1 Market size, by product type, 2017-2030 (USD Million)
8.4.8.2 Market size, by application, 2017-2030 (USD Million)
8.4.8.3 Market size, by modality, 2017-2030 (USD Million)
8.4.8.4 Market size, by end-use, 2017-2030 (USD Million)
8.4.9 Australia
8.4.9.1 Market size, by product type, 2017-2030 (USD Million)
8.4.9.2 Market size, by application, 2017-2030 (USD Million)
8.4.9.3 Market size, by modality, 2017-2030 (USD Million)
8.4.9.4 Market size, by end-use, 2017-2030 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2017-2030 (USD Million)
8.5.2 Market size, by product type, 2017-2030 (USD Million)
8.5.3 Market size, by application, 2017-2030 (USD Million)
8.5.4 Market size, by modality, 2017-2030 (USD Million)
8.5.5 Market size, by end-use, 2017-2030 (USD Million)
8.5.6 Brazil
8.5.6.1 Market size, by product type, 2017-2030 (USD Million)
8.5.6.2 Market size, by application, 2017-2030 (USD Million)
8.5.6.3 Market size, by modality, 2017-2030 (USD Million)
8.5.6.4 Market size, by end-use, 2017-2030 (USD Million)
8.5.7 Mexico
8.5.7.1 Market size, by product type, 2017-2030 (USD Million)
8.5.7.2 Market size, by application, 2017-2030 (USD Million)
8.5.7.3 Market size, by modality, 2017-2030 (USD Million)
8.5.7.4 Market size, by end-use, 2017-2030 (USD Million)
8.6 Middle East and Africa
8.6.1 Market size, by country, 2017-2030 (USD Million)
8.6.2 Market size, by product type, 2017-2030 (USD Million)
8.6.3 Market size, by application, 2017-2030 (USD Million)
8.6.4 Market size, by modality, 2017-2030 (USD Million)
8.6.5 Market size, by end-use, 2017-2030 (USD Million)
8.6.6 South Africa
8.6.6.1 Market size, by product type, 2017-2030 (USD Million)
8.6.6.2 Market size, by application, 2017-2030 (USD Million)
8.6.6.3 Market size, by modality, 2017-2030 (USD Million)
8.6.6.4 Market size, by end-use, 2017-2030 (USD Million)
8.6.7 Saudi Arabia
8.6.7.1 Market size, by product type, 2017-2030 (USD Million)
8.6.7.2 Market size, by application, 2017-2030 (USD Million)
8.6.7.3 Market size, by modality, 2017-2030 (USD Million)
8.6.7.4 Market size, by end-use, 2017-2030 (USD Million)
8.6.8 UAE
8.6.8.1 Market size, by product type, 2017-2030 (USD Million)
8.6.8.2 Market size, by application, 2017-2030 (USD Million)
8.6.8.3 Market size, by modality, 2017-2030 (USD Million)
8.6.8.4 Market size, by end-use, 2017-2030 (USD Million)
Chapter 9 Company Profiles
9.1 Strategy dashboard, 2021
9.2 Alliance Medical (Life Healthcare)
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Aytu Biopharma
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 SWOT analysis
9.4 Bayer Healthcare Pharmaceuticals
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Beijing Beilu Pharmaceutical
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 SWOT analysis
9.6 Bracco Diagnostics, Inc.
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 Curium Pharma
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 Eli Lilly & Company
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 GE Healthcare
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Guerbet Group
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Lantheus Medical Imaging, Inc.
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
9.12 Trivitron Healthcare
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Product landscape
9.12.4 SWOT analysis
